Health Care Equipment

Sensus Healthcare

Sensus Healthcare released FY2026 Q1 earnings on May 7 After-Market (EST), actual revenue USD 3.394 M (forecast USD 5.323 M), actual EPS USD -0.1599 (forecast USD -0.125)

Sensus Healthcare to Release FY2026 Q1 Earnings on May 7 After-Market EST, Forecast Revenue USD 5.323 M, EPS USD -0.125

Sensus Healthcare released FY2025 Q4 earnings on February 12 After-Market EST, actual revenue USD 4.939 M (forecast USD 8.345 M), actual EPS USD -0.1939 (forecast USD -0.07)

Sensus Healthcare released FY2025 earnings on February 12 After-Market EST, actual revenue USD 27.48 M (forecast USD 30.86 M), actual EPS USD -0.4727 (forecast USD -0.3433)

Sensus Healthcare to Release FY2025 Q4 Earnings on February 12 After-Market EST, Forecast Revenue USD 8.345M, EPS USD -0.07

Sensus Healthcare released FY2025 9 Months Earnings on November 6 After-Market EST, with actual revenue of USD 22.54 M and EPS of USD -0.2835

Sensus Healthcare released FY2025 Q3 earnings on November 6 After-Market EST, actual revenue USD 6.884 M (forecast USD 6.313 M), actual EPS USD -0.0599 (forecast USD -0.095)

Sensus Healthcare to Release FY2025 Q3 Earnings on November 6 After-Market EST, Forecast Revenue USD 6.313 M, EPS USD -0.095

Sensus Healthcare released FY2025 Q2 earnings on August 7 After-Market (EST), actual revenue USD 7.315 M (forecast USD 9.301 M), actual EPS USD -0.0635 (forecast USD 0.026)

Sensus Healthcare released FY2025 Semi-Annual earnings on August 7 After-Market (EST), actual revenue USD 15.66 M, actual EPS USD -0.2209

Sensus Healthcare to Release FY2025 Q2 Earnings on August 7 After-Market EST, Forecast Revenue USD 9.301 M, EPS USD 0.026

Sensus Healthcare Partners with ROS to Promote SRT Systems

Sensus Healthcare Inc. Submits Beneficial Ownership Statement

Roth Capital Cuts Sensus Healthcare Earnings Forecast

Sensus Healthcare Inc reports EPS loss above expectations

Earnings report released on May 15, 2025 (BJT) with actual revenue of USD 8.344 M and actual EPS of USD -0.16

Sensus Healthcare to Report Q1 2025 Earnings on May 15, 2025

Sensus Healthcare Inc forecasts EPS of 3 cents and revenue decline

Sensus Healthcare to Release FY2025 Q1 Earnings on May 15 After-Market EST, Forecast Revenue USD 7.234M, EPS USD 0.034

Sensus Healthcare Q4 Earnings Report: EPS of $0.09, Revenue of $13.067 Million

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

SRTS

Sensus Healthcare, Inc. reported a revenue of $3.39M for Q1 2026, a 59% decline from $8.34M in Q1 2025, with a net loss of $2.63M and diluted EPS of $(0.16), unchanged from the previous year. The revenue drop was attributed to fewer unit sales and a shift towards long-term deals. The company reduced operating expenses and has sufficient cash to cover at least 12 months, while inventory increased in anticipation of future sales.

TradingView

SPDR S&P Health Equip

iShares US Medical Devices

Sensus Healthcare 1Q 2026: Revenue $3.39M, EPS $(0.16) — 10-Q Summary

Sensus Healthcare (NASDAQ:SRTS) reported quarterly earnings of ($0.16) EPS, missing estimates by $0.04. Revenue was $3.39 million, below the expected $5.32 million. The company had a negative net margin of 28.09% and a negative return on equity of 15.11%. Despite the disappointing results, management anticipates higher revenue in Q2/H2 due to new reimbursement codes and commercial expansion initiatives. The stock fell 25.1% to $3.08, with analysts rating it as a "Moderate Buy" and a consensus target price of $6.88.

Market Beat

Citigroup

State Street

CITIGROUP INC 6.250 NON CUM SER II PFD WI

State Street® US Equity Premium Inc ETF

Sensus Healthcare (NASDAQ:SRTS) Releases Quarterly Earnings Results, Misses Expectations By $0.04 EPS

MRVI

In Friday's trading session, several health care stocks experienced significant movements. AMN Healthcare Services surged 25.6% to $28.2, while Inovio Pharmaceuticals and Maravai LifeSciences rose 25.28% and 23.22%, respectively. Conversely, AIM ImmunoTech saw a sharp decline of 35.1% to $0.36, with Artivion and Sensus Healthcare also falling by 26.6% and 26.53%. The Q1 earnings reports for many of these companies were released yesterday, influencing stock performance.

benzinga_article

AMN Healthcare Services

Maravai LifeSciences

Inovio Pharma

Artivion

AIM ImmunoTech

Ark Genomic Revolution ETF

Invesco Nasdaq Biotechnology ETF

Direxion S&P Biotech Bull 3X

iShares Global Healthcare

iShares Biotechnology ETF

VanEck Biotech ETF

Proshares Ultra Nasdaq Biotech

VG Health

Invesco Biotechnology & Genome ETF

First Trust NYSE Arca Biotech Index Fd

Health Care Select Sector SPDR

SPDR S&P Biotech

ALPS Medical Breakthrough

iShares US Pharma

Traws Pharma

Co-Diagnostics

PTC Therap

Akanda

Amphastar Pharma

Outset Medical

AIM IMMUNOTECH INC

AIM ImmunoTech Inc.

12 Health Care Stocks Moving In Friday's Intraday Session

Sensus Healthcare shares are trading lower after the company reported worse-than-expected Q1 financial results.

AMLX

In Friday's pre-market session, Traws Pharma (NASDAQ:TRAW) shares surged 37% to $2.33, while Amylyx Pharmaceuticals (NASDAQ:AMLX) rose 18.42% to $18.0. Other gainers included Celldex Therapeutics (NASDAQ:CLDX) up 12.54% to $37.5, and InMed Pharmaceuticals (NASDAQ:INM) up 12% to $0.78. Conversely, Sensus Healthcare (NASDAQ:SRTS) fell 25.1% to $3.08, Absci (NASDAQ:ABSI) dropped 19.66% to $4.62, and Amphastar Pharma (NASDAQ:AMPH) decreased 15.65% to $20.27. Most companies reported Q1 earnings yesterday.

Sensus Healthcare(SRTS.US)

Sensus Healthcare 1Q 2026: Revenue $3.39M, EPS $(0.16) — 10-Q Summary

Sensus Healthcare (NASDAQ:SRTS) Releases Quarterly Earnings Results, Misses Expectations By $0.04 EPS

12 Health Care Stocks Moving In Friday's Intraday Session

Sensus Healthcare shares are trading lower after the company reported worse-than-expected Q1 financial results.

12 Health Care Stocks Moving In Friday's Pre-Market Session

Sensus Healthcare | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 3.394 M